← Back to Search

Corticosteroid

Betamethasone - ACTIVE for Preterm Birth (ACSinPROM Trial)

Phase 2 & 3
Waitlist Available
Led By Richard Porreco, MD
Research Sponsored by Pediatrix
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up anytime during the pregnancy prior to birth (~ 9 months of pregnancy)

Summary

This trial will compare the effects of one versus two courses of antenatal steroids on the incidence of major neonatal morbidity in pregnant women with pre-labor premature rupture of the membranes.

Eligible Conditions
  • Preterm Birth
  • Premature Birth

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~anytime during the pregnancy prior to birth (~ 9 months of pregnancy)
This trial's timeline: 3 weeks for screening, Varies for treatment, and anytime during the pregnancy prior to birth (~ 9 months of pregnancy) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Composite Neonatal Morbidity
Secondary study objectives
Baby's Head Circumference
Baby's birth weight
Gestational age of baby
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Betamethasone - ACTIVEExperimental Treatment1 Intervention
Booster Course of Antenatal Steroids consists of Betamethasone \[12 mg intramuscular injection, 24 hours apart X 2 doses\] or if unavailable may give Dexamethasone \[6 mg intramuscularly 12 hours apart x 4 doses\]
Group II: normal saline - PLACEBOPlacebo Group1 Intervention
Normal saline of equivalent volume given intramuscularly at the equivalent dosing regimes listed in experimental arm.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Betamethasone - ACTIVE
2016
Completed Phase 3
~200

Find a Location

Who is running the clinical trial?

PediatrixLead Sponsor
36 Previous Clinical Trials
18,266 Total Patients Enrolled
Mednax Center for Research, Education, Quality and SafetyLead Sponsor
36 Previous Clinical Trials
18,266 Total Patients Enrolled
Richard Porreco, MDPrincipal InvestigatorPediatrix
3 Previous Clinical Trials
5,390 Total Patients Enrolled
~20 spots leftby Nov 2025